Top Tweets for #CD137
#CD137 in Post-MI Fibrosis: Insights from Knockout Studies
#MyocardialInfarction #Fibrosis
https://t.co/uxVm46OAuX
#OnlineFirst: M9657 Is a Bispecific Tumor-Targeted Anti-#CD137 Agonist That Induces MSLN-Dependent Antitumor Immunity without Liver Inflammation, by Chunxiao Xu, Laura Helming et al.
https://t.co/NWEy1b7MnZ
@EMDOncologyUS
Kick off meeting EFFESO Impresive team🏆 #Immunotherapy #CD137 @LuisPaz_Ares @leadartis @Alvarez_Vallina @AgEInves @CNIOStopCancer @UAI_imas12 @HospitalPdH #Proyectoscolaboraciónpúblicoprivada 🧬🧫🔬
Identifican un mecanismo del receptor #CD137 (4-1BB) que despierta la respuesta inmunitaria frente a tumores
https://t.co/5IjxrcqERi
#ASCO23 #MoffittASCO23 Pleased to be part of this #phase1 team testing the novel #CD137 agonist AGEN2373 for advanced solid tumors @MoffittNews @MoffittResearch
https://t.co/1e7A5NQnaP
Check out our latest Review on @CD_AACR about CD137 (4-1BB)-based Cancer Immunotherapy on its 25th Anniversary. Truly grateful to have made the illustrations of it. Congrats to @DrIgMelero and team. #41BB #CD137 #CancerDiscovery #CancerImmunotherapy . https://t.co/qoHhQXwKPE
Systematic analysis of CD39, CD103, CD137, and PD-1 as biomarkers for naturally occurring tumor antigen-specific TILs
Eiva, Omran, Chacon, Powell Jr.
#CD39 #CD103 #CD137 #PD1 #TumorInfiltratingLymphocytes
@PennMedicine @Penn @TTUHSC
https://t.co/TMa9FBmSCB
Steven Blake, @davidjohnlynn and colleagues from @flinders @sahmriAU show that in mice the gut microbiota impacts hepatoxicity, colitis, and cytokine release induced by immunotherapies (#CD40 #CD137) @EMBLAustralia
This study IDs #CD137 (#41BB) as an actionable target for enhancing #NKcell persistence and function by counteracting #TGFβ suppression. Read more here! https://t.co/Pyk0eRscMc
@AMuntasell @aecc_es @IMIM_research @UABBarcelona @WorldwideCancer @hospitaldelmar
Another fantastic study by @CCI_UoS @UoS_Medicine colleagues, led by Prof @msc_cragg, providing further insights into TNFRs agonism and guiding the development of future TNFR-targeted immunotherapies, including #CD40 and #CD137 mAbs, in @CommsBio https://t.co/jAuT11Uq8F
Newest #publication from the group by our clinician scientist colleague Andrej Stoll (not on Twitter) about the role of #CD137 for #metabolism and #function of #monocytes in the context of #Cancer #Immunotherapy
@LeukemiaJnl @UniFAU
https://t.co/sLCDudlArf
Our researcher Ignacio Melero @CIMA_unav @ClinicaNavarra will share the story of possible treatment strategies based on #CD137 T lymphocyte receptor #AACR21
Leveraging the Immune System in the War on Cancer:
The official digital news source of #AACR21 previews the final plenary session, which begins at 10:45 AM EDT.
@QuezadaLab @sloan_kettering @CIMA_unav
https://t.co/21qX14TEw0
Really excited to anounce first subject dosed with F222 (CD137/PD-L1)!! #fstar #41bb #cd137 #pdl1 #immunotherapy #oncology #clinicaltrial https://t.co/Cg4QxylUv3
Prof Liz Jaffee #PancreaticCancer #immunotherapy Guru @bloombergkimmel gives tour de force review of amazing & promising efforts from her group/impressive effect of triplet I-O/#vaccine + #CD137 + #PD1 on generating CD8+GZMB+ T cells & #CTLA4 & PD1 #SITC2020 @BMS_ImmunOnc_US
Queensland scientists show 4-1BB (#CD137) is a potential immunotherapy target for non-melanoma #skincancer including squamous cell carcinoma & basal cell carcinoma. The study involved #UQDI's #TRI-based A/Prof Graham Leggatt & Dr Stephen Mattarollo.
▶https://t.co/fjelYynGFU
$ONCS @OncoSec #OncoSec 📈🚀
#IntratumoralElectroporation
#Plasmids
#IL12
#IL15
#GITR
#CD137
#CD134
#CD40L
#CD27
$MRK $GILD $FTSV $TRIL $AFMD $ADAP $ONCS $SRNE $MRNA $INO $LPTX $SGMO $IBB $XBI $FATE $NKTR $GSK $AZN $CYCC $BLUE $GWPH $NK $BMY $PIRS $PFE $REGN $SNY $EDIT $ALLO
Today we announced the Notices of Allowance for three new patents covering our interleukin-12 (IL-12) based immunotherapy platform, including #TAVOᵀᴹ, #TAVOᴾᴸᵁˢ, and our EP gene delivery system. Learn more: https://t.co/ZW2UUahHSF #TogetherAgainstCancer
$AGEN advances another discovery, now clear to clinic; CD137 agonist, AGEN2373, which has been specifically designed to overcome
the shortcomings of earlier generation CD137 agonists. https://t.co/iKaOovP32I
#CD137 #Immunotherapy #Cancer
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.9M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Cristiano Ronaldo
@cristiano
111.6M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
97.9M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.2M followers
Taylor Swift
@taylorswift13
82.1M followers
Lady Gaga
@ladygaga
73.6M followers
Virat Kohli
@imvkohli
70.7M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.2M followers
Neymar Jr
@neymarjr
63.6M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.8M followers
Selena Gomez
@selenagomez
61.3M followers
X
@x
60.8M followers